In this regard, mucin-1/KL-6 has been proposed as a serum biomarker useful to detect the presence of ILD, to evaluate disease activity and to predict clinical outcomes in various types of ILDs, such as IPF and CTD-ILD, including PM and DM5,7,13,16,17. The gene discussed is MUC1; the disease is interstitial lung disease.